A Life Threatening Subglottic and Mediastinal Hemangioma in an Infant

Area of Science:

• Pediatric Oncology
• Vascular Malformations
• Pediatric Surgery

Background:

• Subglottic and mediastinal hemangiomas are rare, benign vascular tumors in children.
• These conditions can cause life-threatening airway obstruction requiring medical intervention.
• Existing treatments have variable success rates and potential complications.

Observation:

• A 2-month-old infant presented with stridor due to mediastinal and subglottic hemangioma.
• The infant was treated with propranolol, a beta-blocker medication.
• No surgical intervention or tracheostomy was necessary.

Findings:

• Propranolol demonstrated efficacy in treating the infant's airway-compressing hemangioma.
• The treatment was associated with no reported side effects.
• This case highlights propranolol as a successful non-invasive therapeutic option.

Implications:

• Propranolol represents a safe and effective first-line treatment for infantile hemangiomas affecting the airway.
• Non-invasive management with propranolol can prevent the need for tracheostomy or surgery.
• This approach offers a favorable risk-benefit profile for pediatric patients with subglottic hemangiomas.